Oppenheimer Upgrades Transcat (NASDAQ:TRNS) to “Outperform”

Posted by Brian Himes on Nov 4th, 2026

Transcat (NASDAQ:TRNS – Get Free Report) was upgraded by investment analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a research note issued to investors on Wednesday, MarketBeat.com reports. The brokerage presently has a $115.00 price target on the scientific and technical instruments company’s stock. Oppenheimer‘s target price points to a potential upside of 28.46% from the stock’s current price.

A number of other equities analysts also recently issued reports on the stock. Northland Securities upgraded shares of Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 price target for the company in a report on Wednesday, October 21st. CJS Securities began coverage on shares of Transcat in a research report on Tuesday, October 27th. They set an “outperform” rating and a $115.00 target price on the stock. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Transcat in a report on Tuesday, August 25th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $108.33.

View Our Latest Analysis on Transcat

Transcat Trading Up 1.8%

Shares of TRNS stock opened at $89.52 on Wednesday. The business’s fifty day moving average price is $86.10 and its 200 day moving average price is $81.83. The firm has a market capitalization of $840.59 million, a PE ratio of 241.95 and a beta of 0.61. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.49 and a quick ratio of 2.11. Transcat has a 1-year low of $50.23 and a 1-year high of $100.00.

Transcat (NASDAQ:TRNS – Get Free Report) last released its earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.19. The company had revenue of $97.09 million during the quarter, compared to the consensus estimate of $92.46 million. Transcat had a return on equity of 5.56% and a net margin of 0.99%. As a group, sell-side analysts forecast that Transcat will post 1.79 EPS for the current fiscal year.

Insider Activity

In other Transcat news, Director Christopher P. Gillette sold 504 shares of Transcat stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $94.23, for a total transaction of $47,491.92. Following the completion of the transaction, the director owned 200 shares in the company, valued at approximately $18,846. The trade was a 71.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Craig Cairns purchased 1,050 shares of Transcat stock in a transaction on Thursday, August 6th. The stock was acquired at an average cost of $93.97 per share, for a total transaction of $98,668.50. Following the acquisition, the director directly owned 1,480 shares of the company’s stock, valued at approximately $139,075.60. This represents a 244.19% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Transcat

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Summit Creek Advisors LLC grew its holdings in Transcat by 23.8% during the 3rd quarter. Summit Creek Advisors LLC now owns 58,135 shares of the scientific and technical instruments company’s stock valued at $5,140,000 after buying an additional 11,165 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Transcat in the third quarter worth $221,000. GAMMA Investing LLC raised its holdings in shares of Transcat by 133.6% in the third quarter. GAMMA Investing LLC now owns 1,030 shares of the scientific and technical instruments company’s stock worth $91,000 after acquiring an additional 589 shares during the last quarter. Tidal Investments LLC purchased a new stake in shares of Transcat in the second quarter valued at $688,000. Finally, Integrated Wealth Concepts LLC purchased a new stake in shares of Transcat in the second quarter valued at $32,000. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat News Summary

Here are the key news stories impacting Transcat this week:

Positive Sentiment: Transcat earned $0.64 per share, up from $0.44 a year earlier and above consensus estimates of roughly $0.42–$0.45. Revenue was $97.09 million, topping the $92.46 million estimate. Zacks earnings report
Positive Sentiment: The company raised its fiscal 2027 outlook for service organic growth to the low double digits and is targeting at least 100 basis points of service gross-margin expansion in the second half. That outlook points to continued demand and improving service profitability. Outlook update
Positive Sentiment: Management characterized the quarter as strong, citing double-digit organic service revenue growth and significant service gross-margin expansion. Transcat fiscal second-quarter results

About Transcat

(Get Free Report)

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.